Geoff Macintyre

Research Institute Hospital 12 de Octubre — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

52h-index23.8kcitations176works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(69), Prostate Cancer Treatment and Research(22), Ovarian cancer diagnosis and treatment(17), Genomics and Phylogenetic Studies(16), Genetic factors in colorectal cancer(16)

Publications123 total

Tracking ongoing chromosomal instability using single-cell whole-genome sequencing
2025Open Access
A comprehensive genetic catalog of human double-strand break repair
Science·2025· 5 cited
Predicting resistance to chemotherapy using chromosomal instability signatures
Nature Genetics·2025· 8 citedOpen Access
Forecasting oncogene amplification and tumour suppressor deletion
2025· 1 citedOpen Access
Abstract 6363: Predicting resistance to cytotoxic chemotherapy
Cancer Research·2025
Inherited genome instability
Science·2025· 1 cited
A comprehensive genetic catalog of human double-strand break repair
2024· 2 citedOpen Access
Crowd-sourced benchmarking of single-sample tumor subclonal reconstruction
Nature Biotechnology·2024· 5 citedOpen Access
Abstract 7422: Enabling biomarkers of chromosomal instability for tumor only targeted gene panel sequencing
Cancer Research·2024
scAbsolute: measuring single-cell ploidy and replication status
Genome biology·2024· 12 citedOpen Access
Pan-cancer evolution signatures link clonal expansion to dynamic changes in the tumour immune microenvironment
2023· 2 citedOpen Access
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Nature Communications·2023· 3 citedOpen Access
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma
Nature Communications·2023· 51 citedOpen Access
scAbsolute: measuring single-cell ploidy and replication status
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
eLife·2023· 28 citedOpen Access
Data from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Data from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Figure 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Figure 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
Supplementary Table 1 from Canonical Androstenedione Reduction Is the Predominant Source of Signaling Androgens in Hormone-Refractory Prostate Cancer
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Florian Markowetz(25), Marcin Imieliński(16), Marek Cmero(15), Steven E. Schumacher(15), Paul C. Boutros(14), Iñigo Martincorena(14), Kadir C. Akdemir(13), James D. Brenton(13), David D.L. Bowtell(12), David J. Adams(12), Rameen Beroukhim(11), Niall M. Corcoran(11), Christopher M. Hovens(11), Maxime Tarabichi(10), Kortine Kleinheinz(10), Kerstin Haase(10), Jonas Demeulemeester(10), Dale W. Garsed(10), Peter J. Park(10), Moritz Gerstung(9)